Comparison guide
Use this page to compare how BPC-157, TB-500, and related peptides are marketed, where the evidence boundaries differ, and which explainer to read next.
No "best peptide" score
This page does not rank compounds for your body, goals, or symptoms.
No dosing or stack guidance
Routes, cycles, and combination instructions are excluded on purpose.
Public evidence and policy framing on this page are aligned to repo research notes reviewed on April 14, 2026.
Each card below compares how a compound is usually framed, what this site can safely say in public copy, and the next explainer that adds context without drifting into advice.
Usually marketed for
Broad healing, tissue repair, gut support, and recovery claims.
Safe public boundary
As of April 14, 2026, public discussion still leans heavily on preclinical evidence and limited visible human outcome data.
Primary caution
Mechanistic and animal findings are often stretched into clinical-sounding promises that have not been verified for routine human use.
Usually marketed for
Injury recovery, training rebound, and stacked peptide comparisons.
Safe public boundary
It is a separate experimental peptide with its own thin public human evidence picture; it should not be treated as interchangeable with BPC-157.
Primary caution
Comparison pages often slide into rankings, stacks, and protocol talk instead of showing where the evidence runs out.
Usually marketed for
Skin, cosmetic, and tissue-remodeling discussions.
Safe public boundary
It sits in a different conversation from the recovery-focused BPC-157 and TB-500 marketing loop, so the shared "peptide" label can obscure important context differences.
Primary caution
Do not treat one peptide category as proof that another compound is approved, proven, or appropriate for the same problem.
Readers usually need these framing checks before any one compound-by-compound summary becomes useful.
Which claim is actually being made?
Separate injury-repair, athlete-recovery, gut-health, and cosmetic marketing before comparing compounds sold under the same peptide umbrella.
What evidence level supports it?
Ask whether the claim comes from public human outcomes, preclinical work, or pure marketing copy before treating it as settled.
What regulator or sports body matters?
Approval and anti-doping status are date- and jurisdiction-specific, so one screenshot or retailer page should never stand in for them all.